CareDx (CDNA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $66.68, +3.07% vs the prior close of $64.69.
- Volume 1.30M shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CDNA jumps 3.1% to $66.68. Closed at $66.68, +3.07% vs the prior close of $64.69. Day range $62.21–$68.17, opened at $63.72.
CDNA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CDNA jumps 3.1% to $66.68
- Closed at $66.68, +3.07% vs the prior close of $64.69. Day range $62.21–$68.17, opened at $63.72.
- Volume was 1.30M shares, 1.0x its 50-day average of 1.25M.
- Price is +22.2% vs its 50-day average ($54.57) and +116.5% vs its 200-day average ($30.79).
- 52-week range $14.03–$72.51; today's close sits at 90% of that range, 8.0% below the 52-week high.
Oct 14, 2026 — CDNA dips 1.1% to $64.69
- Closed at $64.69, -1.13% vs the prior close of $65.43. Day range $63.34–$67.73, opened at $64.40.
- Volume was 1.19M shares, 0.9x its 50-day average of 1.26M.
- Price is +19.5% vs its 50-day average ($54.14) and +111.7% vs its 200-day average ($30.55).
- 52-week range $14.03–$72.51; today's close sits at 87% of that range, 10.8% below the 52-week high.
Oct 13, 2026 — CDNA jumps 3.7% to $65.43
- Closed at $65.43, +3.66% vs the prior close of $63.12. Day range $62.22–$67.39, opened at $62.57.
- Volume was 1.50M shares, 1.2x its 50-day average of 1.29M.
- Price is +21.6% vs its 50-day average ($53.79) and +115.7% vs its 200-day average ($30.33).
- 52-week range $14.03–$72.51; today's close sits at 88% of that range, 9.8% below the 52-week high.
Oct 12, 2026 — CDNA dips 0.9% to $63.12
- Closed at $63.12, -0.86% vs the prior close of $63.67. Day range $61.34–$64.47, opened at $63.28.
- Volume was 900.00K shares, 0.7x its 50-day average of 1.32M.
- Price is +18.1% vs its 50-day average ($53.44) and +109.7% vs its 200-day average ($30.10).
- 52-week range $13.95–$72.51; today's close sits at 84% of that range, 12.9% below the 52-week high.
Oct 9, 2026 — CDNA rises 2.4% to $63.67
- Closed at $63.67, +2.36% vs the prior close of $62.21. Day range $62.21–$65.13, opened at $62.21.
- Volume was 895.60K shares, 0.7x its 50-day average of 1.34M.
- Price is +20.0% vs its 50-day average ($53.05) and +113.1% vs its 200-day average ($29.88).
- 52-week range $13.95–$72.51; today's close sits at 85% of that range, 12.2% below the 52-week high.
Oct 8, 2026 — CDNA dips 1.3% to $62.21, 3 down days in a row
- Closed at $62.21, -1.32% vs the prior close of $63.04. Day range $61.19–$63.45, opened at $61.88.
- Volume was 1.57M shares, 1.2x its 50-day average of 1.32M.
- Price is +18.4% vs its 50-day average ($52.54) and +109.7% vs its 200-day average ($29.66).
- 52-week range $13.95–$72.51; today's close sits at 82% of that range, 14.2% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — CDNA dips 1.2% to $63.04
- Closed at $63.04, -1.18% vs the prior close of $63.79. Day range $61.38–$65.10, opened at $61.38.
- Volume was 1.70M shares, 1.3x its 50-day average of 1.31M.
- Price is +21.2% vs its 50-day average ($52.00) and +114.0% vs its 200-day average ($29.45).
- 52-week range $13.95–$72.51; today's close sits at 84% of that range, 13.1% below the 52-week high.
Oct 6, 2026 — CDNA slides 8.7% to $63.79 on 2.0x normal volume
- Closed at $63.79, -8.68% vs the prior close of $69.85. Day range $63.74–$72.51, opened at $70.89.
- Volume was 2.56M shares, 2.0x its 50-day average of 1.27M — unusually heavy trading.
- Price is +24.0% vs its 50-day average ($51.46) and +118.2% vs its 200-day average ($29.23).
- 52-week range $13.95–$72.51; today's close sits at 85% of that range, 12.0% below the 52-week high.
Oct 5, 2026 — CDNA jumps 4.0% to $69.85, a 52-week high, 4 up days in a row
- Closed at $69.85, +4.02% vs the prior close of $67.15. Day range $66.17–$70.75, opened at $66.89.
- Volume was 1.64M shares, 1.3x its 50-day average of 1.25M.
- Price is +37.2% vs its 50-day average ($50.91) and +140.8% vs its 200-day average ($29.01).
- 52-week range $13.95–$70.75; today's close sits at 98% of that range, 1.3% below the 52-week high.
- That makes 4 straight gains.
Oct 2, 2026 — CDNA rises 1.4% to $67.15, a 52-week high, 3 up days in a row
- Closed at $67.15, +1.39% vs the prior close of $66.23. Day range $65.88–$69.80, opened at $66.33.
- Volume was 1.59M shares, 1.3x its 50-day average of 1.23M.
- Price is +33.6% vs its 50-day average ($50.25) and +133.5% vs its 200-day average ($28.76).
- 52-week range $13.95–$69.80; today's close sits at 95% of that range, 3.8% below the 52-week high.
- That makes 3 straight gains.
CDNA latest news & SEC filings
Every SEC filing by or about CDNA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Novack Jeffrey Adam had withheld for taxes 997 shares at $66.23 (≈$66.03K) on Oct 1, 2026; now holds 105,078
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hanna John Walter Jr had withheld for taxes 8,511 shares at $66.23 (≈$563.68K) on Oct 1, 2026; now holds 644,937
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kennedy Keith had withheld for taxes 3,018 shares at $66.23 (≈$199.88K) on Oct 1, 2026; now holds 208,686
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Meng Jessica had withheld for taxes 2,619 shares at $66.23 (≈$173.46K) on Oct 1, 2026; now holds 158,980
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Goldberg Michael received an award of 588 shares on Oct 2, 2026; now holds 62,326
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · 8-K/A — Amended current report
Amended current report
- Item 2.01 — Completed an acquisition or sale of assets.
Sep 15, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · S-8 — Registration of shares for employee stock plans (S-8)
Registration of shares for employee stock plans (S-8)
Jul 30, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $131.95M (prior year $86.68M) (+52.2% vs Jun 30, 2025)
- Net income: $110.64M (prior year -$8.57M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $2.07 (prior year -$0.16) (swung to profit vs Jun 30, 2025)
Jul 30, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 27, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 7, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade CDNA
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: Apr 28, 2026, Apr 16, 2026, Feb 24, 2026. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.99% (largest 13.0%).
- Liquidity: about 1.56M shares (≈$104.26M) trade per day on average.
- 52-week position: $66.68 vs a range of $14.03–$72.51 (90% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: George Bickerstaff sold 20,000 shares on Aug 5, 2026.
- Latest filings: 10-Q Jul 30, 2026; 8-K Jul 30, 2026; 8-K Jul 7, 2026.
- Share count: 51.73M shares outstanding (Jul 27, 2026), -2.8% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
CDNA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 63.72 | 68.17 | 62.21 | 66.68 | 1.30M |
| Oct 14, 2026 | 64.40 | 67.73 | 63.34 | 64.69 | 1.19M |
| Oct 13, 2026 | 62.57 | 67.39 | 62.22 | 65.43 | 1.50M |
| Oct 12, 2026 | 63.28 | 64.47 | 61.34 | 63.12 | 900.00K |
| Oct 9, 2026 | 62.21 | 65.13 | 62.21 | 63.67 | 895.60K |
| Oct 8, 2026 | 61.88 | 63.45 | 61.19 | 62.21 | 1.57M |
| Oct 7, 2026 | 61.38 | 65.10 | 61.38 | 63.04 | 1.70M |
| Oct 6, 2026 | 70.89 | 72.51 | 63.74 | 63.79 | 2.56M |
| Oct 5, 2026 | 66.89 | 70.75 | 66.17 | 69.85 | 1.64M |
| Oct 2, 2026 | 66.33 | 69.80 | 65.88 | 67.15 | 1.59M |
| Oct 1, 2026 | 64.96 | 67.29 | 64.15 | 66.23 | 1.91M |
| Sep 30, 2026 | 63.87 | 65.63 | 63.12 | 65.00 | 1.77M |
| Sep 29, 2026 | 64.74 | 65.50 | 62.90 | 64.02 | 796.10K |
| Sep 28, 2026 | 62.30 | 65.50 | 62.30 | 64.60 | 1.08M |
| Sep 25, 2026 | 61.33 | 65.19 | 60.51 | 63.68 | 2.35M |
| Sep 24, 2026 | 55.29 | 63.09 | 54.52 | 61.37 | 2.50M |
| Sep 23, 2026 | 56.25 | 57.16 | 54.00 | 54.31 | 1.91M |
| Sep 22, 2026 | 54.44 | 56.85 | 53.78 | 56.49 | 1.97M |
| Sep 21, 2026 | 53.82 | 54.86 | 53.50 | 54.33 | 766.70K |
| Sep 18, 2026 | 53.97 | 54.46 | 53.12 | 53.83 | 1.38M |
About CareDx
CareDx (CDNA) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in BRISBANE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1217234.
CDNA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| George Bickerstaff | Director | Aug 6, 2026 |
| Christine Cournoyer | Director | Aug 6, 2026 |
| Fred E Cohen | Director | Jun 16, 2026 |
| Michael Goldberg | Director | Aug 6, 2026 |
| Suresh Gunasekaran | Director | Jun 16, 2026 |
| John Walter Jr Hanna | President and CEO | Jul 17, 2026 |
| Richard Bryan Riggsbee | Director | Jun 16, 2026 |
| Arthur A Torres | Director | May 18, 2026 |
| Hannah Valantine | Director | Jul 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John Walter Jr Hanna | President and CEO | Jul 17, 2026 |
| Keith Kennedy | CFO & COO | Sep 15, 2026 |
| Jessica Meng | Chief Commercial Officer | Sep 15, 2026 |
| Jeffrey Adam Novack | Secretary and General Counsel | Aug 6, 2026 |
| Nathan Smith | Chief Financial Officer | Feb 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 5, 2026 | George Bickerstaff | Sale | 20,000 | $46.29 |
| Aug 5, 2026 | Jeffrey Adam Novack | Sale | 2,188 | $46.15 |
| Aug 5, 2026 | Jeffrey Adam Novack | Sale | 500 | $46.75 |
| Aug 4, 2026 | Michael Goldberg | Sale | 44,700 | $47.06 |
| Aug 4, 2026 | Christine Cournoyer | Sale | 16,000 | $46.94 |
| Jul 16, 2026 | Hannah Valantine | Sale | 100 | $36.55 |
| Jul 16, 2026 | Hannah Valantine | Sale | 28,679 | $36.14 |
| Jul 16, 2026 | John Walter Jr Hanna | Sale | 68,000 | $39.01 |
| Jul 16, 2026 | John Walter Jr Hanna | Sale | 50,000 | $36.11 |
| Jun 29, 2026 | John Walter Jr Hanna | Sale | 39,900 | $29.24 |
| Jun 26, 2026 | John Walter Jr Hanna | Sale | 100 | $29.00 |
| Jun 15, 2026 | John Walter Jr Hanna | Sale | 17,683 | $24.03 |
| Jun 15, 2026 | Hannah Valantine | Sale | 12,103 | $23.11 |
| Jun 11, 2026 | John Walter Jr Hanna | Sale | 21,998 | $24.02 |
| Jun 4, 2026 | John Walter Jr Hanna | Sale | 4,835 | $24.00 |
CDNA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $379.81M | $-21.35M | -0.40 | $42.03M |
| Dec 31, 2024 | $333.79M | $52.55M | 0.93 | $38.05M |
| Dec 31, 2023 | $280.32M | $-190.28M | -3.54 | $-18.39M |
| Dec 31, 2022 | $321.79M | $-76.61M | -1.44 | $-25.24M |
| Dec 31, 2021 | $296.40M | $-30.66M | -0.59 | $-19.29M |
Latest balance sheet: total assets $532.99M, total liabilities $107.39M, cash $373.64M (as of Jun 30, 2026).
CDNA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $38.10 |
| Apr 28, 2026 | 8-K Item 2.02 (results) | $21.91 |
| Apr 16, 2026 | 8-K Item 2.02 (results) | $22.42 |
| Feb 24, 2026 | 8-K Item 2.02 (results) | $19.25 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $20.57 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $14.52 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $13.10 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $16.88 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $21.10 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $25.07 |
| Nov 4, 2024 | 8-K Item 2.02 (results) | $22.93 |
| Oct 15, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Quest Diagnostics (DGX)Guardant Health (GH)Labcorp (LH)Celcuity (CELC)Caris Life Sciences (CAI)Grail (GRAL)Fortrea (FTRE)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CDNA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.